[HTML][HTML] Therapeutic management options for stage III non-small cell lung cancer
SM Yoon, T Shaikh, M Hallman - World journal of clinical oncology, 2017 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
[PDF][PDF] WJCO
SM Yoon, T Shaikh, M Hallman - 2017 - pdfs.semanticscholar.org
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
[引用][C] Therapeutic management options for stage III non-small cell lung cancer
SM Yoon, T Shaikh, M Hallman - World Journal of Clinical Oncology, 2017 - cir.nii.ac.jp
Therapeutic management options for stage III non-small cell lung cancer | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Therapeutic management options for stage III non-small cell lung cancer
SM Yoon, T Shaikh, M Hallman - World journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
Therapeutic management options for stage III non-small cell lung cancer.
SM Yoon, T Shaikh, M Hallman - World Journal of Clinical Oncology, 2017 - europepmc.org
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
[HTML][HTML] Therapeutic management options for stage III non-small cell lung cancer
SM Yoon, T Shaikh, M Hallman - World Journal of Clinical Oncology, 2017 - wjgnet.com
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
Therapeutic management options for stage III non-small cell lung cancer.
SM Yoon, T Shaikh, M Hallman - World Journal of Clinical Oncology, 2017 - europepmc.org
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …